Position in OGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$71
-$1,075 QoQ
Shares Held
12
-80.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARK SHEPTOFF FINANCIAL PLANNING, LLC holds $15,714,112 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,538 | $8,263,675 | |
| 2 | ABBV |
AbbVie Inc.
|
20,810 | $5,236,628 | |
| 3 | LLY |
ELI LILLY & Co
|
705 | $845,598 | |
| 4 | NVS |
Novartis AG
|
5,120 | $802,406 | |
| 5 | PFE |
Pfizer Inc
|
12,734 | $306,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,000 | $172,860 | |
| 7 | MRK |
Merck & Co., Inc.
|
400 | $51,400 | |
| 8 | AMGN |
Amgen Inc
|
50 | $18,106 |
All Filings in OGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71 | 12 | Shares | Sole | 2026-05-11 | |
| 2024-03-31 | $1,146 | 61 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $735 | 51 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $885 | 51 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,061 | 51 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,199 | 51 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,424 | 51 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $93 | 4 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $135 | 4 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $139 | 4 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $121 | 4 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||